For individuals aged less than 60 months, there was no significant association between RANBP2 rs2462788 C>T polymorphism and glioma risk (AOR = 0.90, 95% CI = 0.33–2.45, pa = 0.832). This evidence concerns the gene RANBP2 and central nervous system cancer.